Skip to main content

Volume 14, Issue 1 (Winter 2013)  [12]

Persistent link to this collection:

Recently Added

Bringing Dormant GRAS(E) to Bloom: Reviving the GRASE Concept for Drugs

Puchalski, Emily (2013-02-12)
The cost of getting a new drug to market was estimated at $802 million in 2003, and more recent estimates have placed the cost at $1.3 billion and $1.7 billion. Making the commercial drug development process even more ...

Developing a Durable Right to Health Care

Fuse Brown, Erin C. (2013-02-12)
The Patient Protection and Affordable Care Act’s (ACA) signature accomplishment was the creation of a statutory right to health care for the uninsured. This is a momentous change in policy, addressing one of the most vexing ...

Mistake-Proofing Medicine: Legal Considerations and Healthcare Quality Implications

Grout, John R.; Hill, John W.; Langvardt, Arlen W. (2013-02-12)
In 1999, the Institute of Medicine estimated that approximately 98,000 deaths resulted annually from medical errors. This shocking number does not appear to have lessened during the intervening years. Mistake-proofing ...

Technopanics, Threat Inflation, and the Danger of an Information Technology Precautionary Principle

Thierer, Adam (2013-02-12)
Fear is an extremely powerful motivational force. In public policy debates, appeals to fear are often used in an attempt to sway opinion or bolster the case for action. Such appeals are used to convince citizens that threats ...

The Flaws of Stem Cell Legislation: Sherley, Brüstle, and Future Policy Challenges Posed by Induced Pluripotent Stem Cells

Diamond, Nicholas J. (2013-02-12)
In this article, I first contextualize the origins of disagreement over the nature and extent of human embryonic stem cell (hESC) research regulation. By analyzing two key pieces of hESC legislation as considered in two ...

View more